News
- News
News
PROCURE renews its mission to better reflect its commitment to patients and their loved ones
September 25, 2026
As part of its 2026–2029 strategic plan, PROCURE is renewing its mission to better reflect its commitment to patients and their loved ones at every stage of the prostate cancer journey. This evolution reaffirms the organization’s role and the key pillars that will guide its work over the coming years: clinical excellence, research, compassionate support and social leadership. A renewed mission driven by the same ambition: to mobilize the expertise and resources needed to foster hope and make a meaningful difference in the journey of those affected by the disease.
PROCURE Joins the Coalition Against Exclusion
September 24, 2026
PROCURE is joining the Coalition Against Exclusion alongside Obesity Matters, Diabetes Québec, the Quebec Lung Association and the Canadian Alopecia Areata Foundation. Together, these organizations serve as a voice for patients and advocate for treatments for several conditions that are currently excluded from eligibility for reimbursement to be evaluated based on scientific evidence. For PROCURE, this commitment notably aims to highlight the importance of managing erectile dysfunction following prostate cancer treatment.
New Leadership for PROCURE
September 16, 2026
Marie-Claire Richer, inf., Ph. D., ASC, becomes Chair of PROCURE’s Board of Directors, succeeding Cédric Bisson, M.D. and LL.B., after 18 years as Chair. A Board member since 2021, she will help ensure a smooth transition and continuity, while Mr. Bisson will remain actively involved as Past Chair.
Her experience in patient care, research and healthcare leadership will be a valuable asset as PROCURE enters its next stage of development. This transition reflects the organization’s continued commitment to its mission and strategic direction.
$3 million to support six research projects
25 mars 2026
PROCURE, in partnership with the Cancer Research Society (CRS), announces $3 million in funding to support six innovative prostate cancer research projects. Each project will receive $500,000 over three years and covers a range of approaches, including the discovery of new biomarkers, advanced medical imaging, precision nutrition, and the development of targeted therapies. This support highlights the commitment of both organizations to accelerate scientific progress and improve the diagnosis and treatment of the most common cancer in men.
CF Montréal Partners With PROCURE for Its New Away Jersey
February 10, 2026
CF Montréal, a committed partner for nearly 20 years, has unveiled its new away jersey, which will feature the PROCURE logo for the next three seasons. Through this gesture, the Club aims to shine a spotlight on the fight against prostate cancer and raise awareness about a disease that affects one in eight men. Each jersey sold will directly support the cause, with a financial commitment enhanced by the Saputo family. Bold design, a powerful message, and community mobilization: this jersey stands as a symbol of unity and hope.
Over $500,000 Raised by our CEO During his Cross-Canada Cycling Challenge
July 16, 2025
As part of PROCURE’s CEO Challenge, Laurent Proulx cycled across Canada, riding more than 200 kilometres per day to raise awareness about prostate cancer. Completed in just 32 days, this remarkable challenge raised $535,000 in support of research. Far beyond the distance covered, every kilometre helped move the cause forward and underscored the importance of supporting men affected by prostate cancer and their loved ones.
$2M to Support Prostate Cancer Research
September 11, 2024
PROCURE is proud to announce a strategic partnership with the Cancer Research Society (CRS) to support innovative prostate cancer research. Together, the two organizations will invest $2 million over three years to fund four major research projects, each valued at $500,000.
Informations complémentaires - Cancer de la prostate
Is prostate cancer hereditary?
Understanding the hereditary and genetic aspects of this disease can provide valuable information to both individuals affected and their families.
Genetics and prostate cancer
Do you have a family history of cancer? Your doctor might recommend genetic screening.
Symptoms, risk and screening
Are you over 50 or experiencing urinary problems? Discover why early screening for prostate diseases is important.
From prostate to screening
Learn about the role of your prostate, related diseases, symptoms to watch out for and risk factors.
Genetic predisposition to prostate cancer
Although rare, some hereditary genetic mutations can increase your risk of prostate cancer.
Sources et références
Dernière révision médicale et éditoriale: janvier 2024. Voir notre comité de valiation de nos pages Web et nos collaborateurs en cliquant ici.
Relevant and additional information
Here, you’ll find a selection of key pages and resources that may address your questions or concerns. Scroll through to explore essential information available on our site.
Do you have a curved penis?
Can I prevent BRCA-related prostate cancer?
Is prostate cancer hereditary?
Genetics and prostate cancer
Symptoms, risk and screening
From prostate to screening
